SK hynix to expand production capacity in China as it mulls Solidigm IPO, report claims — second phase of fab could boost local production by 50%

SK hynix, via its Solidigm unit, is resuming investment at its Dalian, China fab, reports Sedaily, after a four-year pause. The second phase is expected to add about 50% capacity to ~150,000 wafer starts per month by 2027. The Korea Herald says SK hynix is considering a Solidigm NASDAQ listing. Candidate: SK hynix and Solidigm.

Original reporting
Published Aug 11, 2026, 5:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 6:05 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SK hynix to expand production capacity in China as it mulls Solidigm IPO, report claims — second phase of fab could boost local production by 50% — source image
Decision brief

The 30-second read

$000660.KSBullishMed
01

Why it matters

Resumed Dalian investment, a second fab phase targeting mass production in 1H 2027, and new U.S. equipment licenses collectively point to improved China output capability. The potential Solidigm NASDAQ listing is a capital-structure catalyst but remains unconfirmed.

02

Market read

Traders may price in improved NAND/SSD supply capacity and potential capital-raise optionality, but should discount for IPO non-confirmation and execution risk.

03

What to watch

U.S. licensing is time-bounded through 2026, and demand for premium SSDs could normalize; also, any IPO structure could change valuation and capital allocation more than near-term production economics.

Relevance 7/10Novelty 6/10Timing: reported ahead of potential Solidigm IPO decision and Dalian equipment installation window (as early as November).

Background

SK hynix acquired Intel’s 3D NAND and SSD business in 2021 and formed Solidigm; it paused Dalian capacity expansion in 2022-2023 due to downturn and U.S. export controls.

Company-level read

Ticker impact

$000660.KSBullishMedium confidence
Context

SK hynix plans to expand Dalian fab output by 50% in 2027 and is considering a Solidigm NASDAQ listing to fund it.

Expected impact

Near-term sentiment likely positive on expansion and IPO optionality, but execution and regulatory/market-conditions risk remain.

Evidence & confidence

The article cites resumed Dalian investment, a second-phase ramp timeline, and a potential NASDAQ listing to raise capital while retaining control. However, it also notes SK hynix has not officially confirmed the IPO plan, reducing certainty.

Market effects

If real, higher China NAND capacity and new process adoption could intensify supply expectations for 3D NAND and data-center SSDs, affecting pricing dynamics.

China fab ramp and U.S. license renewals reduce the probability of prolonged output constraints from export controls.

Potential Solidigm IPO and increased premium SSD availability could shift competitive positioning in data-center storage globally.

Counterpoint

The IPO is not confirmed and the fab ramp depends on equipment installation and mass-production timing; supply gains may be delayed or partially offset by broader memory-cycle weakness.

Key entities

  • SK hynix

    Plans to boost Dalian fab output via Solidigm and is considering a Solidigm NASDAQ listing to raise capital while retaining control.

  • Solidigm

    Solidigm subsidiary operating the Dalian fab; reportedly resumed investment, completed second-phase construction, and plans new floating gate 3D NAND production.

  • United States government

    Granted SK hynix and Samsung annual licenses to ship advanced semiconductor production equipment to China through 2026.

Related articles

SK Hynix to mull options for US$3bn China plant

Bloomberg reports SK Hynix is reviewing options for its Chongqing, China semiconductor packaging and testing plant, including possibly bringing in an investor or selling a stake that could value the facility at about US$3 billion, according to people familiar with the matter. Separately, SK Hynix plans a 54 trillion won (US$38 billion) South Korea expansion for DRAM and NAND, citing AI-era memory demand.

$000660.KSMedAI 8/10

SK Hynix commits $38B to new fabs as Nvidia AI memory demand surges

SK Hynix said its board approved about 54.3 trillion won ($38.3B) for new memory chip fabs in South Korea, with spending through 2031, according to Reuters. About 35.2 trillion won will fund a second DRAM fab in Yongin (Y2) and 19.1 trillion won a NAND plant in Cheongju. The plan follows record Q2 revenue of 79.3 trillion won, up 257% YoY, per CNBC.

Morgan Stanley says memory chip selloff is over, reaffirms targets for Samsung Electronics, SK Hynix

Morgan Stanley said in an Asia tech equity report that the recent memory chip selloff is over and valuations offer a tactical re-entry. It kept price targets unchanged for SK Hynix at 2.6 million won and Samsung Electronics at 375,000 won. The bank raised SK Hynix FY2026 EPS by 13% and cut Samsung FY2026 forecasts by 10%, citing slower price growth risk after Q4.

$000660.KSMedAI 8/10

SK hynix approves $38.1 billion investment in two new fabs for AI memory supply

SK hynix’s board approved a 54.3 trillion won (about $38.1 billion) investment to build two new fabs in South Korea for AI memory supply. About $24.9 billion will fund the Yongin Y2 DRAM/HBM fab, with construction starting July 2027 and first cleanroom June 2029. About $13.2 billion will fund the Cheongju M17 NAND fab, starting Feb 2027 and first cleanroom Dec 2028, citing Omdia demand growth projections.

Samsung's 'One-Team' Chip Strategy Speeds Up HBM4E Output

Samsung Electronics says it achieved about 80% yields in mass production of sixth-gen HBM4, attributing progress to a coordinated “turnkey” approach across memory, foundry and advanced packaging. Samsung expects HBM4 revenue to more than triple in Q3 and exceed 60% of total HBM revenue in H2. UBS projects Samsung HBM share rising to 41% in 2025 vs SK hynix 39%.